Hao Liu

Title: Hao Liu: Innovator in Antiparasitic and Cancer Treatment Compounds

Introduction

Hao Liu is a prominent inventor based in Raleigh, NC (US), known for his significant contributions to the field of medicinal chemistry. With a total of 3 patents, he has focused on developing innovative compounds that address critical health issues, particularly in the treatment of parasitic infections and cancer.

Latest Patents

Hao Liu's latest patents include groundbreaking inventions such as antiparasitic compounds, which relate to 1,2,4-thiadiazole derivatives used to treat parasites. Another notable patent involves inhibitors of Akt activity, where he provides substituted fused naphthyridine derivatives that selectively inhibit one or two of the Akt isoforms. This invention also encompasses compositions comprising these inhibitory compounds and methods for administering them to patients in need of cancer treatment.

Career Highlights

Throughout his career, Hao Liu has worked with esteemed companies such as Merck Sharp & Dohme Corp. and Scynexis, Inc. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Hao Liu has collaborated with notable colleagues, including Michael Robert Peel and Weiming Fan. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Hao Liu's work in developing antiparasitic and cancer treatment compounds showcases his dedication to improving healthcare through innovation. His contributions to medicinal chemistry continue to have a significant impact on the field.